Share Price and Basic Stock Data
Last Updated: December 12, 2025, 7:46 pm
| PEG Ratio | 5.89 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
COSYN Ltd operates in the IT Consulting and Software sector, a space that has seen significant volatility, especially post-pandemic. As of the latest reporting period, the company’s stock price stood at ₹24.0 with a market capitalization of ₹18.0 Cr. Over the past few quarters, COSYN’s revenue has displayed a pattern of fluctuation. For instance, sales recorded in June 2022 were ₹2.98 Cr, which spiked to ₹5.16 Cr in September 2022, before experiencing a drop to ₹3.29 Cr in December 2022. This inconsistency continued into 2023, where revenues ranged from ₹3.11 Cr to ₹4.20 Cr. The latest figures indicate sales of ₹4.80 Cr for March 2024. Such swings highlight the company’s struggle with maintaining stable revenue streams, which could be a concern for potential investors looking for predictability in earnings.
Profitability and Efficiency Metrics
Profitability metrics for COSYN Ltd reveal a mixed performance. The company’s operating profit margin (OPM) has seen significant fluctuations, recording a low of -31.51% in June 2023 but rebounding to 46.48% in June 2025. This dramatic swing indicates substantial variability in operational efficiency, a factor that could raise eyebrows among investors. The reported net profit for FY 2025 was ₹0.16 Cr, translating to an earnings per share (EPS) of ₹0.21. While this reflects a positive trajectory from the previous year, the price-to-earnings ratio (P/E) of 106 suggests that the stock may be overvalued relative to its earnings. Moreover, the return on equity (ROE) stood at 5.63%, while return on capital employed (ROCE) was at a mere 3.13%. This points to a need for COSYN to enhance its profitability and return metrics to attract more discerning investors.
Balance Sheet Strength and Financial Ratios
Examining COSYN’s balance sheet reveals a robust position in terms of financial stability, particularly with zero borrowings reported. This absence of debt enhances the company’s risk profile, allowing for greater flexibility in operations. The reserves stood at ₹22.32 Cr, providing a cushion for potential downturns. However, the company’s cash conversion cycle has ballooned to an alarming 2,528.39 days, which suggests inefficiencies in managing receivables and inventory. Such a prolonged cycle can strain liquidity and operational effectiveness. Furthermore, with a price-to-book value ratio (P/BV) of 0.57x, COSYN appears undervalued relative to its book value, which might pique the interest of value-focused investors. Yet, the low return ratios indicate that while the company has a solid foundation, it must improve its operational efficiency to maximize shareholder value.
Shareholding Pattern and Investor Confidence
The shareholding pattern of COSYN Ltd reveals a significant promoter stake of 54.46%, indicating strong control by the founders and management. This level of promoter holding can often instill confidence among retail investors, as it suggests alignment of interests between management and shareholders. However, the absence of Foreign Institutional Investors (FIIs) and the negligible stake held by Domestic Institutional Investors (DIIs) at 0% raise concerns about the stock’s attractiveness to larger institutional players. The public holding stands at 45.53%, with the number of shareholders slightly declining to 4,849, which could suggest waning interest or confidence among retail investors. This mix of concentrated ownership and lack of institutional backing could be a double-edged sword, providing stability but also limiting potential growth in stock value.
Outlook, Risks, and Final Insight
Looking ahead, COSYN Ltd presents a complex investment case. The company’s strong promoter backing and debt-free balance sheet are commendable strengths, but the erratic revenue trends and low operational efficiency raise valid concerns about its future trajectory. Investors should be cautious of the extended cash conversion cycle, which could adversely affect liquidity and operational agility. Moreover, the high P/E ratio might deter value-conscious investors looking for stocks with more attractive earnings multiples. While the potential for recovery exists, particularly if COSYN can stabilize its revenue and improve profit margins, the risks associated with its current operational inefficiencies cannot be overlooked. Navigating these waters will require careful consideration, as the company’s ability to convert its solid foundational metrics into sustainable profitability will ultimately dictate its attractiveness in the competitive IT consulting landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 49.2 Cr. | 15.6 | 15.6/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 151 Cr. | 140 | 194/99.8 | 23.1 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 25.6 Cr. | 200 | 310/140 | 18.3 | 26.7 | 0.50 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.28 Cr. | 1.08 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,491.18 Cr | 558.12 | 86.50 | 123.78 | 0.54% | 14.89% | 20.93% | 6.84 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.98 | 5.16 | 3.29 | 3.65 | 3.11 | 4.20 | 3.39 | 4.80 | 3.43 | 3.29 | 3.31 | 4.78 | 0.71 |
| Expenses | 2.64 | 4.73 | 3.01 | 3.40 | 4.09 | 3.66 | 3.19 | 3.65 | 3.21 | 3.08 | 3.05 | 6.30 | 0.38 |
| Operating Profit | 0.34 | 0.43 | 0.28 | 0.25 | -0.98 | 0.54 | 0.20 | 1.15 | 0.22 | 0.21 | 0.26 | -1.52 | 0.33 |
| OPM % | 11.41% | 8.33% | 8.51% | 6.85% | -31.51% | 12.86% | 5.90% | 23.96% | 6.41% | 6.38% | 7.85% | -31.80% | 46.48% |
| Other Income | 0.05 | 0.05 | 0.05 | 0.08 | 0.06 | 0.07 | 0.07 | 0.03 | 0.02 | 0.01 | 0.01 | 2.13 | 0.04 |
| Interest | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.05 | 0.06 | 0.04 | 0.06 | 0.07 | 0.06 | 0.17 | 0.12 |
| Depreciation | 0.23 | 0.24 | 0.24 | 0.25 | 0.19 | 0.19 | 0.20 | 0.20 | 0.13 | 0.13 | 0.14 | 0.16 | 0.20 |
| Profit before tax | 0.14 | 0.22 | 0.07 | 0.06 | -1.13 | 0.37 | 0.01 | 0.94 | 0.05 | 0.02 | 0.07 | 0.28 | 0.05 |
| Tax % | 35.71% | 27.27% | 42.86% | 83.33% | 0.88% | 2.70% | 100.00% | 13.83% | 20.00% | 50.00% | 28.57% | 75.00% | 20.00% |
| Net Profit | 0.09 | 0.16 | 0.04 | 0.01 | -1.14 | 0.36 | 0.00 | 0.82 | 0.04 | 0.01 | 0.04 | 0.07 | 0.04 |
| EPS in Rs | 0.12 | 0.21 | 0.05 | 0.01 | -1.52 | 0.48 | 0.00 | 1.09 | 0.05 | 0.01 | 0.05 | 0.09 | 0.05 |
Last Updated: August 19, 2025, 8:40 pm
Below is a detailed analysis of the quarterly data for COSYN Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.71 Cr.. The value appears to be declining and may need further review. It has decreased from 4.78 Cr. (Mar 2025) to 0.71 Cr., marking a decrease of 4.07 Cr..
- For Expenses, as of Jun 2025, the value is 0.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.30 Cr. (Mar 2025) to 0.38 Cr., marking a decrease of 5.92 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.33 Cr.. The value appears strong and on an upward trend. It has increased from -1.52 Cr. (Mar 2025) to 0.33 Cr., marking an increase of 1.85 Cr..
- For OPM %, as of Jun 2025, the value is 46.48%. The value appears strong and on an upward trend. It has increased from -31.80% (Mar 2025) to 46.48%, marking an increase of 78.28%.
- For Other Income, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 2.13 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 2.09 Cr..
- For Interest, as of Jun 2025, the value is 0.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.17 Cr. (Mar 2025) to 0.12 Cr., marking a decrease of 0.05 Cr..
- For Depreciation, as of Jun 2025, the value is 0.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.16 Cr. (Mar 2025) to 0.20 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.28 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.23 Cr..
- For Tax %, as of Jun 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 75.00% (Mar 2025) to 20.00%, marking a decrease of 55.00%.
- For Net Profit, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 0.07 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 0.03 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.05. The value appears to be declining and may need further review. It has decreased from 0.09 (Mar 2025) to 0.05, marking a decrease of 0.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.50 | 22.08 | 27.71 | 31.47 | 42.70 | 39.57 | 29.90 | 19.89 | 13.41 | 14.84 | 13.73 | 14.38 | 12.09 |
| Expenses | 10.07 | 19.29 | 23.08 | 23.87 | 31.63 | 33.06 | 24.63 | 17.49 | 14.22 | 13.45 | 12.55 | 14.92 | 12.81 |
| Operating Profit | 2.43 | 2.79 | 4.63 | 7.60 | 11.07 | 6.51 | 5.27 | 2.40 | -0.81 | 1.39 | 1.18 | -0.54 | -0.72 |
| OPM % | 19.44% | 12.64% | 16.71% | 24.15% | 25.93% | 16.45% | 17.63% | 12.07% | -6.04% | 9.37% | 8.59% | -3.76% | -5.96% |
| Other Income | 0.04 | 0.07 | 0.21 | 0.24 | 0.32 | 0.43 | 0.28 | 0.29 | 2.76 | 0.23 | 0.23 | 2.18 | 2.19 |
| Interest | 0.42 | 0.42 | 0.45 | 0.28 | 1.71 | 1.81 | 0.54 | 0.23 | 0.08 | 0.17 | 0.44 | 0.66 | 0.42 |
| Depreciation | 0.80 | 0.97 | 0.75 | 0.85 | 0.94 | 1.76 | 2.64 | 2.38 | 1.71 | 0.96 | 0.77 | 0.56 | 0.63 |
| Profit before tax | 1.25 | 1.47 | 3.64 | 6.71 | 8.74 | 3.37 | 2.37 | 0.08 | 0.16 | 0.49 | 0.20 | 0.42 | 0.42 |
| Tax % | 34.40% | -46.26% | -2.20% | 2.09% | 18.76% | 30.56% | 20.68% | 25.00% | 62.50% | 38.78% | 75.00% | 59.52% | |
| Net Profit | 0.82 | 2.14 | 3.71 | 6.57 | 7.09 | 2.34 | 1.88 | 0.06 | 0.07 | 0.30 | 0.04 | 0.16 | 0.16 |
| EPS in Rs | 1.10 | 2.85 | 4.95 | 8.76 | 9.45 | 3.12 | 2.51 | 0.08 | 0.09 | 0.40 | 0.05 | 0.21 | 0.20 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 11.42% | 10.58% | 16.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 160.98% | 73.36% | 77.09% | 7.91% | -67.00% | -19.66% | -96.81% | 16.67% | 328.57% | -86.67% | 300.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -87.61% | 3.72% | -69.17% | -74.91% | 47.34% | -77.15% | 113.48% | 311.90% | -415.24% | 386.67% |
COSYN Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -13% |
| 3 Years: | 3% |
| TTM: | -24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -23% |
| 5 Years: | -39% |
| 3 Years: | 32% |
| TTM: | -87% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 1% |
| 3 Years: | 9% |
| 1 Year: | -53% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 0% |
| 3 Years: | 1% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 3:06 pm
Balance Sheet
Last Updated: December 4, 2025, 2:41 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.42 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 |
| Reserves | 3.85 | 4.43 | 8.15 | 14.20 | 20.39 | 22.22 | 21.68 | 21.69 | 21.76 | 22.06 | 22.10 | 22.26 | 22.32 |
| Borrowings | 2.28 | 2.55 | 2.39 | 0.85 | 4.42 | 3.56 | 1.39 | 0.33 | 0.66 | 0.49 | 1.79 | 2.05 | 0.00 |
| Other Liabilities | 9.30 | 9.39 | 9.88 | 11.67 | 7.03 | 10.26 | 12.81 | 7.30 | 6.74 | 6.75 | 6.19 | 7.91 | 10.24 |
| Total Liabilities | 22.85 | 23.87 | 27.92 | 34.22 | 39.34 | 43.54 | 43.38 | 36.82 | 36.66 | 36.80 | 37.58 | 39.72 | 40.06 |
| Fixed Assets | 4.89 | 2.78 | 3.40 | 3.43 | 3.59 | 7.66 | 6.24 | 4.86 | 6.65 | 6.25 | 5.68 | 3.79 | 3.46 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 1.31 | 0.00 | 0.61 | 1.17 | 1.18 | 1.58 | 2.38 | 2.23 | 2.85 |
| Investments | 0.00 | 0.00 | 0.01 | 1.84 | 2.20 | 2.28 | 2.31 | 2.34 | 2.38 | 2.42 | 2.42 | 2.42 | 2.42 |
| Other Assets | 17.96 | 21.09 | 24.51 | 28.95 | 32.24 | 33.60 | 34.22 | 28.45 | 26.45 | 26.55 | 27.10 | 31.28 | 31.33 |
| Total Assets | 22.85 | 23.87 | 27.92 | 34.22 | 39.34 | 43.54 | 43.38 | 36.82 | 36.66 | 36.80 | 37.58 | 39.72 | 40.06 |
Below is a detailed analysis of the balance sheet data for COSYN Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.50 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.50 Cr..
- For Reserves, as of Sep 2025, the value is 22.32 Cr.. The value appears strong and on an upward trend. It has increased from 22.26 Cr. (Mar 2025) to 22.32 Cr., marking an increase of 0.06 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2.05 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 2.05 Cr..
- For Other Liabilities, as of Sep 2025, the value is 10.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.91 Cr. (Mar 2025) to 10.24 Cr., marking an increase of 2.33 Cr..
- For Total Liabilities, as of Sep 2025, the value is 40.06 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 39.72 Cr. (Mar 2025) to 40.06 Cr., marking an increase of 0.34 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3.46 Cr.. The value appears to be declining and may need further review. It has decreased from 3.79 Cr. (Mar 2025) to 3.46 Cr., marking a decrease of 0.33 Cr..
- For CWIP, as of Sep 2025, the value is 2.85 Cr.. The value appears strong and on an upward trend. It has increased from 2.23 Cr. (Mar 2025) to 2.85 Cr., marking an increase of 0.62 Cr..
- For Investments, as of Sep 2025, the value is 2.42 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.42 Cr..
- For Other Assets, as of Sep 2025, the value is 31.33 Cr.. The value appears strong and on an upward trend. It has increased from 31.28 Cr. (Mar 2025) to 31.33 Cr., marking an increase of 0.05 Cr..
- For Total Assets, as of Sep 2025, the value is 40.06 Cr.. The value appears strong and on an upward trend. It has increased from 39.72 Cr. (Mar 2025) to 40.06 Cr., marking an increase of 0.34 Cr..
Notably, the Reserves (22.32 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.15 | 0.24 | 2.24 | 6.75 | 6.65 | 2.95 | 3.88 | 2.07 | -1.47 | 0.90 | -0.61 | -2.59 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 116.80 | 118.36 | 170.58 | 198.10 | 84.97 | 188.27 | 209.60 | 244.98 | 340.23 | 267.11 | 332.04 | 347.99 |
| Inventory Days | 804.21 | 316.12 | 34.44 | 2,377.30 | ||||||||
| Days Payable | 714.85 | 606.16 | 118.98 | 196.91 | ||||||||
| Cash Conversion Cycle | 116.80 | 118.36 | 259.94 | -91.94 | 84.97 | 103.72 | 209.60 | 244.98 | 340.23 | 267.11 | 332.04 | 2,528.39 |
| Working Capital Days | 95.78 | 79.02 | 109.20 | 110.76 | 80.61 | 95.01 | 117.56 | 200.76 | 290.97 | 248.91 | 323.53 | 287.37 |
| ROCE % | 13.44% | 13.49% | 25.15% | 34.44% | 38.10% | 15.80% | 9.27% | 1.03% | 0.81% | 2.20% | 2.08% | 2.62% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.21 | 0.05 | 0.33 | -0.20 | -0.54 |
| Diluted EPS (Rs.) | 0.21 | 0.05 | 0.33 | -0.20 | -0.54 |
| Cash EPS (Rs.) | 0.96 | 1.08 | 1.63 | 2.33 | 3.20 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 36.56 | 36.35 | 36.38 | 36.05 | 36.26 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 36.56 | 36.35 | 36.38 | 36.05 | 36.26 |
| Revenue From Operations / Share (Rs.) | 19.74 | 20.67 | 20.10 | 17.93 | 26.53 |
| PBDIT / Share (Rs.) | 1.81 | 1.52 | 2.00 | 2.50 | 3.45 |
| PBIT / Share (Rs.) | 1.06 | 0.48 | 0.69 | -0.04 | -0.30 |
| PBT / Share (Rs.) | 0.54 | 0.25 | 0.58 | -0.08 | -0.53 |
| Net Profit / Share (Rs.) | 0.21 | 0.04 | 0.32 | -0.21 | -0.56 |
| NP After MI And SOA / Share (Rs.) | 0.21 | 0.04 | 0.32 | -0.20 | -0.53 |
| PBDIT Margin (%) | 9.17 | 7.34 | 9.93 | 13.96 | 12.99 |
| PBIT Margin (%) | 5.35 | 2.32 | 3.45 | -0.22 | -1.16 |
| PBT Margin (%) | 2.78 | 1.21 | 2.88 | -0.48 | -2.01 |
| Net Profit Margin (%) | 1.07 | 0.22 | 1.63 | -1.17 | -2.11 |
| NP After MI And SOA Margin (%) | 1.07 | 0.22 | 1.63 | -1.12 | -2.02 |
| Return on Networth / Equity (%) | 0.58 | 0.12 | 0.90 | -0.56 | -1.48 |
| Return on Capital Employeed (%) | 2.87 | 1.31 | 1.88 | -0.10 | -0.84 |
| Return On Assets (%) | 0.42 | 0.09 | 0.71 | -0.43 | -1.15 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Asset Turnover Ratio (%) | 0.40 | 0.44 | 0.42 | 0.37 | 0.50 |
| Current Ratio (X) | 2.75 | 2.87 | 3.22 | 3.26 | 3.28 |
| Quick Ratio (X) | 2.25 | 2.23 | 2.69 | 2.81 | 2.85 |
| Inventory Turnover Ratio (X) | 2.96 | 0.15 | 0.19 | 0.19 | 0.19 |
| Interest Coverage Ratio (X) | 3.57 | 6.60 | 17.71 | 53.52 | 15.24 |
| Interest Coverage Ratio (Post Tax) (X) | 1.42 | 1.20 | 3.91 | -3.49 | -1.48 |
| Enterprise Value (Cr.) | 10.24 | 23.94 | 8.25 | 11.51 | 8.95 |
| EV / Net Operating Revenue (X) | 0.69 | 1.54 | 0.54 | 0.85 | 0.44 |
| EV / EBITDA (X) | 7.54 | 21.03 | 5.50 | 6.13 | 3.46 |
| MarketCap / Net Operating Revenue (X) | 1.06 | 1.70 | 0.88 | 1.17 | 0.75 |
| Price / BV (X) | 0.57 | 0.96 | 0.48 | 0.58 | 0.55 |
| Price / Net Operating Revenue (X) | 1.06 | 1.70 | 0.88 | 1.17 | 0.75 |
| EarningsYield | 0.01 | 0.00 | 0.01 | -0.01 | -0.02 |
After reviewing the key financial ratios for COSYN Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.21, marking an increase of 0.16.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.21, marking an increase of 0.16.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 3. It has decreased from 1.08 (Mar 24) to 0.96, marking a decrease of 0.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.56. It has increased from 36.35 (Mar 24) to 36.56, marking an increase of 0.21.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.56. It has increased from 36.35 (Mar 24) to 36.56, marking an increase of 0.21.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 19.74. It has decreased from 20.67 (Mar 24) to 19.74, marking a decrease of 0.93.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.81. This value is below the healthy minimum of 2. It has increased from 1.52 (Mar 24) to 1.81, marking an increase of 0.29.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.06. This value is within the healthy range. It has increased from 0.48 (Mar 24) to 1.06, marking an increase of 0.58.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.54. This value is within the healthy range. It has increased from 0.25 (Mar 24) to 0.54, marking an increase of 0.29.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.21, marking an increase of 0.17.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.21, marking an increase of 0.17.
- For PBDIT Margin (%), as of Mar 25, the value is 9.17. This value is below the healthy minimum of 10. It has increased from 7.34 (Mar 24) to 9.17, marking an increase of 1.83.
- For PBIT Margin (%), as of Mar 25, the value is 5.35. This value is below the healthy minimum of 10. It has increased from 2.32 (Mar 24) to 5.35, marking an increase of 3.03.
- For PBT Margin (%), as of Mar 25, the value is 2.78. This value is below the healthy minimum of 10. It has increased from 1.21 (Mar 24) to 2.78, marking an increase of 1.57.
- For Net Profit Margin (%), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 5. It has increased from 0.22 (Mar 24) to 1.07, marking an increase of 0.85.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 8. It has increased from 0.22 (Mar 24) to 1.07, marking an increase of 0.85.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 15. It has increased from 0.12 (Mar 24) to 0.58, marking an increase of 0.46.
- For Return on Capital Employeed (%), as of Mar 25, the value is 2.87. This value is below the healthy minimum of 10. It has increased from 1.31 (Mar 24) to 2.87, marking an increase of 1.56.
- For Return On Assets (%), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 5. It has increased from 0.09 (Mar 24) to 0.42, marking an increase of 0.33.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.40. It has decreased from 0.44 (Mar 24) to 0.40, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 2.75. This value is within the healthy range. It has decreased from 2.87 (Mar 24) to 2.75, marking a decrease of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 2.25. This value exceeds the healthy maximum of 2. It has increased from 2.23 (Mar 24) to 2.25, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.96. This value is below the healthy minimum of 4. It has increased from 0.15 (Mar 24) to 2.96, marking an increase of 2.81.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.57. This value is within the healthy range. It has decreased from 6.60 (Mar 24) to 3.57, marking a decrease of 3.03.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 3. It has increased from 1.20 (Mar 24) to 1.42, marking an increase of 0.22.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10.24. It has decreased from 23.94 (Mar 24) to 10.24, marking a decrease of 13.70.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 1.54 (Mar 24) to 0.69, marking a decrease of 0.85.
- For EV / EBITDA (X), as of Mar 25, the value is 7.54. This value is within the healthy range. It has decreased from 21.03 (Mar 24) to 7.54, marking a decrease of 13.49.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.70 (Mar 24) to 1.06, marking a decrease of 0.64.
- For Price / BV (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 0.96 (Mar 24) to 0.57, marking a decrease of 0.39.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.70 (Mar 24) to 1.06, marking a decrease of 0.64.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in COSYN Ltd:
- Net Profit Margin: 1.07%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 2.87% (Industry Average ROCE: 14.89%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.58% (Industry Average ROE: 20.93%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.42
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.25
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 102 (Industry average Stock P/E: 86.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.07%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 3rd Floor, TP House, D.No 1 98/9/J/15, Plot No 15(P), Hyderabad Telangana 500081 | comsec@cosyn.in http://www.cosyn.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravi Vishnu | Managing Director |
| Mrs. Ravi Kasturi | Non Executive Woman Director |
| Mr. Rama Rao Karumanchi | Independent Director |
| Mr. Chennaiah Athota | Independent Director |
| Mr. Aeruva Bhopal Reddy | Executive Director |
| Mr. Srinivasu Uggirala | Independent Director |
FAQ
What is the intrinsic value of COSYN Ltd?
COSYN Ltd's intrinsic value (as of 14 December 2025) is 186.50 which is 703.88% higher the current market price of 23.20, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 17.4 Cr. market cap, FY2025-2026 high/low of 47.5/20.4, reserves of ₹22.32 Cr, and liabilities of 40.06 Cr.
What is the Market Cap of COSYN Ltd?
The Market Cap of COSYN Ltd is 17.4 Cr..
What is the current Stock Price of COSYN Ltd as on 14 December 2025?
The current stock price of COSYN Ltd as on 14 December 2025 is 23.2.
What is the High / Low of COSYN Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of COSYN Ltd stocks is 47.5/20.4.
What is the Stock P/E of COSYN Ltd?
The Stock P/E of COSYN Ltd is 102.
What is the Book Value of COSYN Ltd?
The Book Value of COSYN Ltd is 39.8.
What is the Dividend Yield of COSYN Ltd?
The Dividend Yield of COSYN Ltd is 0.00 %.
What is the ROCE of COSYN Ltd?
The ROCE of COSYN Ltd is 3.13 %.
What is the ROE of COSYN Ltd?
The ROE of COSYN Ltd is 5.63 %.
What is the Face Value of COSYN Ltd?
The Face Value of COSYN Ltd is 10.0.